APA

Toledano E., Ortiz A. M., Ivorra-Cortes J., Montes N., Beltran A., Rodríguez-Rodriguez L., Carmona L. & González-Álvaro I. (20180731). Are rheumatologists adhering to the concepts window of opportunity and treat-to-target? Earlier and more intense disease-modifying anti-rheumatic drug treatment over time in patients with early arthritis in the PEARL study. : Clinical and experimental rheumatology.

Chicago

Toledano Esther, Ortiz Ana M, Ivorra-Cortes Jose, Montes Nuria, Beltran Amada, Rodríguez-Rodriguez Luis, Carmona Loreto and González-Álvaro Isidoro. 20180731. Are rheumatologists adhering to the concepts window of opportunity and treat-to-target? Earlier and more intense disease-modifying anti-rheumatic drug treatment over time in patients with early arthritis in the PEARL study. : Clinical and experimental rheumatology.

Harvard

Toledano E., Ortiz A. M., Ivorra-Cortes J., Montes N., Beltran A., Rodríguez-Rodriguez L., Carmona L. and González-Álvaro I. (20180731). Are rheumatologists adhering to the concepts window of opportunity and treat-to-target? Earlier and more intense disease-modifying anti-rheumatic drug treatment over time in patients with early arthritis in the PEARL study. : Clinical and experimental rheumatology.

MLA

Toledano Esther, Ortiz Ana M, Ivorra-Cortes Jose, Montes Nuria, Beltran Amada, Rodríguez-Rodriguez Luis, Carmona Loreto and González-Álvaro Isidoro. Are rheumatologists adhering to the concepts window of opportunity and treat-to-target? Earlier and more intense disease-modifying anti-rheumatic drug treatment over time in patients with early arthritis in the PEARL study. : Clinical and experimental rheumatology. 20180731.